Catalog Number | CBCL-0573 |
Price | Online Inquiry |
Unit Quantity | 5 x 10^6 cells / 1.0 ml |
The CHO-Human BTLA-Stable Cell Line is engineered to express the receptor full-length human BTLA (Uniprot: Q7Z6A9-1), used to mimic cancer target cells. When co-cultured with human HVEM Reporter Cell, the BTLA/HVEM interaction drives NF-kB-mediated luminescence. Blocking the BTLA/HVEM interaction by either anti-BTLA or anti-HVEM antibodies results in a decrease in luminescence.
Useful for cell-based BTLA binding assay
BTLA (B and T Lymphocyte Attenuator) is an inhibitory receptor expressed on T cells, B cells, and NK cells. It binds to HVEM (TNFRSF14) and delivers inhibitory signals that suppress lymphocyte activation, promoting immune tolerance.
Category | Immune Checkpoint Cell Lines |
Cell Line Name | CHO-Human BTLA-Stable Cell Line |
Protein Family | B and T lymphocyte attenuator family |
Gene | BTLA |
Species | Hamster |
Host Cell Line | CHO |
Cell Type | Chinese hamster ovary cell line |
Morphology | Epithelial |
Growth Properties | Adherent |
Selection Marker | Puromycin (2 μg/mL) |
Recommended Medium | F-12K + 10% FBS |
Freeze Medium | Serum-free cell cryopreservation medium |
Storage Method | Frozen in liquid nitrogen. |
Stability | Validated for at least 10 passages |
Mycoplasma | Negative |
Sterility Testing | Negative |
Shipping | Shipping in dry ice |
Biosafety Level | BSL-1 |
Caution | For Research Use Only |